drugset / Trial / NCT03099603
A Study of HTD1801 in Healthy Subjects
RandomizedSequentialQuadruple-blindTreatment
Summary
This is a randomized, double blind, single center, ascending single dose study to evaluate the safety, tolerability, and PK of HTD1801.
Timeline
- Start
- 2017-03-24
- Primary completion
- 2017-07-11
- Completion
- 2017-10-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | berberine ursodeoxycholate | Small molecule | 0.5 g | — |
| Comparator | berberine ursodeoxycholate | Small molecule | 1 g | — |
| Comparator | berberine ursodeoxycholate | Small molecule | 2 g | — |
| Comparator | berberine ursodeoxycholate | Small molecule | 4 g | — |